Cedrick Forum Fanatic

Topics: 322 Posts: 2,042
| | 07/07/06 - 12:00 AM  
 
|   #1 |
A 45 year old man who is undergoing dialysis for chronic renal failure stars receiving erythropoietin therapy he has a history of type 1 diabetes mellitus,peripheral neuropathy and well controlled hypertension exacerbation of which of the following is most likely to occur in this patient ? a.-chronic renal insufficeincy b.-diabetes mellitus c.-hypertension d.-osteitis fibrosa cystica e.-peripheral neuropathy
|
| star1 Forum Guru

Topics: 93 Posts: 827
| | 07/07/06 - 12:09 AM  
 
|   #2 |
C hypertension
|
| Cedrick Forum Fanatic

Topics: 322 Posts: 2,042
| | 07/07/06 - 12:15 AM  
 
|   #3 |
hey star
|
| star1 Forum Guru

Topics: 93 Posts: 827
| | 07/07/06 - 12:27 AM  
 
|   #4 |
Cedrick tedo bem when is your exam? you seem to be present online all the time tchau
|
| robin082006 Forum Hero

Topics: 471 Posts: 5,123
| | 07/07/06 - 06:41 AM  
 
|   #5 |
C yeah Cedrick online all the time and funny too
___________________ The Key to Succeed is Patience.
|
| sridevibandaru24 Forum Guru
Topics: 33 Posts: 434
| | 07/07/06 - 07:38 AM  
 
|   #6 |
c
|
| MRMAVERICK Forum Guru

Topics: 46 Posts: 933
| | 07/12/06 - 01:46 AM  
 
|   #7 |
C
___________________ 245/264/CS pass All on first attempt/2006 Grad/1 month Observership/1 US LOR/Need VISA
|
| muzammil Forum Guru

Topics: 16 Posts: 690
| | 07/12/06 - 10:53 AM  
 
|   #8 |
definitly c
|
| Musuq Forum Guru

Topics: 103 Posts: 425
| | 10/23/06 - 11:56 AM  
 
|   #9 |
WHY?
|
| Musuq Forum Guru

Topics: 103 Posts: 425
| | 10/23/06 - 12:00 PM  
 
|   #10 |
Mechanism of erythropoietin-induced hypertension. Chronic administration of erythropoietin (EPO) is associated with an increase in arterial blood pressure in patients and animals with chronic renal failure (CRF). Several mechanisms have been considered in the pathogenesis of EPO-induced hypertension. These include the possible role of the rise of hematocrit and erythrocyte mass, changes in production or sensitivity to endogenous vasopressors, alterations in vascular smooth-muscle ionic milieu, dysregulation of production or responsiveness to endogenous vasodilatory factors, a direct vasopressor action of EPO, and finally arterial remodeling through stimulation of vascular cell growth.
|
|
| |
| | | | | | | | | | |